Barbados Eliminates Mother-to-Child HIV Transmission With Zero Cases Reported
Barbados recorded zero new cases of mother-to-child HIV transmission between 2022 and 2024, earning official validation from the World Health Organization on October 30. The Caribbean island reduced transmission to a level no longer considered a public health problem, driven by universal prenatal care and free treatment access.
The WHO milestone rests on high coverage rates across the island’s public health sector. During the 2022–2024 monitoring window, 98 percent of pregnant women received prenatal care, 98 percent underwent HIV screening, and 98 percent of mothers diagnosed with HIV received antiretroviral therapy. Free testing and treatment apply regardless of nationality while protecting patient privacy.
Fifteen countries and territories across the Americas have now achieved validation or significant milestones in eliminating mother-to-child transmission of HIV, syphilis, or hepatitis B. The Bahamas and the Turks and Caicos Islands received validation in 2026, while Brazil reached the milestone in 2025. Jamaica, Saint Vincent and the Grenadines, and Belize previously secured validation for eliminating both HIV and syphilis transmission.
Suriname Seeks Validation While Addressing Care Gaps
Suriname works toward the same WHO validation but has not yet met the criteria. A study published in 2023 in the Pan American Journal of Public Health examined data for 279 mothers with HIV and their 317 children born between 2016 and 2018, revealing both progress and persistent gaps in the healthcare system.
The research found that 89.3 percent of the studied cases successfully prevented mother-to-child transmission. Among pregnant women with HIV, 84.2 percent received antiretroviral treatment, and 95.5 percent of exposed infants received preventive medication.
The data also identified vulnerabilities in maternal care delivery. Only 71.5 percent of women in the cohort underwent an HIV test during pregnancy, 15 percent received no prenatal care, and 8 percent delivered outside a medical facility. Access to healthcare in interior regions remains a primary challenge for national health authorities.
Supplies Distributed to Strengthen Regional Healthcare
The Pan American Health Organization supported Surinamese healthcare providers in May 2026 with a donation of 334 bottles of benzathine benzylpenicillin to treat syphilis. The Regional Health Service and the Medical Mission distributed these antibiotics to frontline clinics to reduce pregnancy and birth complications.
The Medical Mission received 22 combined HIV and syphilis rapid test kits and five microscopes from PAHO in July 2026. These diagnostics expand screening capacity across remote interior regions as part of broader initiatives targeting vertical transmission of infectious diseases.
Frequently Asked Questions About Elimination Milestones
What criteria does the WHO use to validate elimination?
Validation requires a country to demonstrate that new infection rates have fallen below specific public health thresholds over a defined period. Governments must also prove that health systems maintain high test and treatment coverage while upholding international monitoring and human rights standards.
How does Barbados fund its maternal HIV program?
The government provides free HIV testing and antiretroviral treatments to all pregnant women regardless of nationality, supported by long-term public health investments in universal care.
What specific hurdles does Suriname face in reaching validation?
Researchers cite delayed prenatal registration, limited testing coverage in rural interior regions, and out-of-hospital deliveries as key obstacles that prevent universal treatment access for expectant mothers.
Keep reading